Adjuvant incorporated lipid nanoparticles for enhanced mRNA-mediated cancer immunotherapy†
Abstract
For mRNA mediated cancer immunotherapy, Pam3 was incorporated as an adjuvant within lipid nanoparticles (LNPs) with OVA mRNA. The developed Pam3 incorporated LNPs showed successful expression of tumor antigens with enhanced immune stimulation. We demonstrated that the synergies of Pam3 LNPs could greatly improve the efficacy of tumor prevention by mRNA vaccines.
- This article is part of the themed collection: Biomimetic Therapeutics